Papers

7

Total Citations

54

H-Index

4

About

Giovanni Mazzucato is a leading urological surgeon and researcher whose work focuses on improving outcomes for prostate cancer patients, particularly through robot-assisted radical prostatectomy (RARP) and advanced salvage surgery. His major contributions center on understanding how advanced age and high-risk disease features influence prognosis, demonstrating that elderly patients face higher rates of disease progression despite modern surgical techniques. Mazzucato has also pioneered the use of robot-assisted PSMA-radioguided salvage surgery using the novel SENSEI® drop-in gamma probe, a minimally invasive approach for treating oligorecurrent prostate cancer that correlates intraoperative measurements with preoperative imaging. His research validating the 2012 Briganti nomogram as a predictor of disease progression in both intermediate- and high-risk patients has provided clinicians with powerful tools for risk stratification. With papers accumulating over 50 citations, including his highly cited work on age and prostate cancer outcomes, Mazzucato’s impact is evident in his ability to refine surgical decision-making and personalize treatment. His integration of cutting-edge radioguided technology with established prognostic models marks him as a key figure advancing precision oncology in urology.

Research Focus

Key Achievements

4
H-Index
7
Papers
54
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Advanced age portends poorer prognosis after radical prostatectomy: a single center experience
30 citations · 2022
📈 Most Prolific Year: 2024 (5 Papers)
🤝 Key Collaborators: 47
🏛 Institutions: University of Verona, Azienda Ospedaliera Universitaria Integrata Verona

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago